Prostate Cancer Diagnosis and Treatment Market, Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Prostate Cancer Diagnosis and Treatment in Global, including the following market information:
Global Prostate Cancer Diagnosis and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate Cancer Diagnosis and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prostate Specific Antigen Test (PSA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnosis and Treatment include Abbott Laboratories, AbbVie, Active Biotech, Amgen, Astellas Pharma, AstraZeneca, Bavarian Nordic, Bayer and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Cancer Diagnosis and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnosis and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Diagnosis and Treatment Market Segment Percentages, by Type, 2021 (%)
Global Prostate Cancer Diagnosis and Treatment Market Segment Percentages, by Application, 2021 (%)
Global Prostate Cancer Diagnosis and Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnosis and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate Cancer Diagnosis and Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Prostate Cancer Diagnosis and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate Cancer Diagnosis and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prostate Specific Antigen Test (PSA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnosis and Treatment include Abbott Laboratories, AbbVie, Active Biotech, Amgen, Astellas Pharma, AstraZeneca, Bavarian Nordic, Bayer and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Cancer Diagnosis and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnosis and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Diagnosis and Treatment Market Segment Percentages, by Type, 2021 (%)
- Prostate Specific Antigen Test (PSA)
- Digital Rectal Exam (DRE)
Global Prostate Cancer Diagnosis and Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Diagnostic clinics
- Research centers
Global Prostate Cancer Diagnosis and Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnosis and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate Cancer Diagnosis and Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- AbbVie
- Active Biotech
- Amgen
- Astellas Pharma
- AstraZeneca
- Bavarian Nordic
- Bayer
- Bristol-Myers Squibb
- Dendreon
- Endo
- Ferring Pharmaceuticals
- GE Healthcare
- GSK
- Ipsen
- Johnson & Johnson
- Pfizer
- Sanofi
- Siemens Healthineers
- Takeda
- Teva Pharmaceutical
- Tolmar Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Prostate Cancer Diagnosis and Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnosis and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT OVERALL MARKET SIZE
2.1 Global Prostate Cancer Diagnosis and Treatment Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Diagnosis and Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Prostate Cancer Diagnosis and Treatment Players in Global Market
3.2 Top Global Prostate Cancer Diagnosis and Treatment Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnosis and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnosis and Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Cancer Diagnosis and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnosis and Treatment Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnosis and Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnosis and Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Diagnosis and Treatment Market Size Markets, 2021 & 2028
4.1.2 Prostate Specific Antigen Test (PSA)
4.1.3 Digital Rectal Exam (DRE)
4.2 By Type - Global Prostate Cancer Diagnosis and Treatment Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnosis and Treatment Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Diagnosis and Treatment Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnosis and Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Diagnostic clinics
5.1.4 Research centers
5.2 By Application - Global Prostate Cancer Diagnosis and Treatment Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnosis and Treatment Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Diagnosis and Treatment Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Prostate Cancer Diagnosis and Treatment Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Diagnosis and Treatment Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnosis and Treatment Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Diagnosis and Treatment Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028
6.3.2 US Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.3.3 Canada Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.3.4 Mexico Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028
6.4.2 Germany Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.3 France Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.4 U.K. Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.5 Italy Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.6 Russia Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.8 Benelux Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028
6.5.2 China Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.5.3 Japan Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.5.4 South Korea Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.5.6 India Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028
6.6.2 Brazil Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.6.3 Argentina Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028
6.7.2 Turkey Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.7.3 Israel Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.7.5 UAE Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.1.4 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 AbbVie
7.2.1 AbbVie Corporate Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.2.4 AbbVie Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.2.5 AbbVie Key News
7.3 Active Biotech
7.3.1 Active Biotech Corporate Summary
7.3.2 Active Biotech Business Overview
7.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.3.4 Active Biotech Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.3.5 Active Biotech Key News
7.4 Amgen
7.4.1 Amgen Corporate Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.4.4 Amgen Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.4.5 Amgen Key News
7.5 Astellas Pharma
7.5.1 Astellas Pharma Corporate Summary
7.5.2 Astellas Pharma Business Overview
7.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.5.4 Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.5.5 Astellas Pharma Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.6.4 AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Corporate Summary
7.7.2 Bavarian Nordic Business Overview
7.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.7.4 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.7.5 Bavarian Nordic Key News
7.8 Bayer
7.8.1 Bayer Corporate Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.8.4 Bayer Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.8.5 Bayer Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.9.4 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.9.5 Bristol-Myers Squibb Key News
7.10 Dendreon
7.10.1 Dendreon Corporate Summary
7.10.2 Dendreon Business Overview
7.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.10.4 Dendreon Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.10.5 Dendreon Key News
7.11 Endo
7.11.1 Endo Corporate Summary
7.11.2 Endo Business Overview
7.11.3 Endo Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.11.4 Endo Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.11.5 Endo Key News
7.12 Ferring Pharmaceuticals
7.12.1 Ferring Pharmaceuticals Corporate Summary
7.12.2 Ferring Pharmaceuticals Business Overview
7.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.12.4 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.12.5 Ferring Pharmaceuticals Key News
7.13 GE Healthcare
7.13.1 GE Healthcare Corporate Summary
7.13.2 GE Healthcare Business Overview
7.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.13.4 GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.13.5 GE Healthcare Key News
7.14 GSK
7.14.1 GSK Corporate Summary
7.14.2 GSK Business Overview
7.14.3 GSK Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.14.4 GSK Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.14.5 GSK Key News
7.15 Ipsen
7.15.1 Ipsen Corporate Summary
7.15.2 Ipsen Business Overview
7.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.15.4 Ipsen Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.15.5 Ipsen Key News
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Corporate Summary
7.16.2 Johnson & Johnson Business Overview
7.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.16.4 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.16.5 Johnson & Johnson Key News
7.17 Pfizer
7.17.1 Pfizer Corporate Summary
7.17.2 Pfizer Business Overview
7.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.17.4 Pfizer Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.17.5 Pfizer Key News
7.18 Sanofi
7.18.1 Sanofi Corporate Summary
7.18.2 Sanofi Business Overview
7.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.18.4 Sanofi Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.18.5 Sanofi Key News
7.19 Siemens Healthineers
7.19.1 Siemens Healthineers Corporate Summary
7.19.2 Siemens Healthineers Business Overview
7.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.19.4 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.19.5 Siemens Healthineers Key News
7.20 Takeda
7.20.1 Takeda Corporate Summary
7.20.2 Takeda Business Overview
7.20.3 Takeda Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.20.4 Takeda Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.20.5 Takeda Key News
7.21 Teva Pharmaceutical
7.21.1 Teva Pharmaceutical Corporate Summary
7.21.2 Teva Pharmaceutical Business Overview
7.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.21.4 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.21.5 Teva Pharmaceutical Key News
7.22 Tolmar Pharmaceuticals
7.22.1 Tolmar Pharmaceuticals Corporate Summary
7.22.2 Tolmar Pharmaceuticals Business Overview
7.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.22.4 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.22.5 Tolmar Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Prostate Cancer Diagnosis and Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnosis and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PROSTATE CANCER DIAGNOSIS AND TREATMENT OVERALL MARKET SIZE
2.1 Global Prostate Cancer Diagnosis and Treatment Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Diagnosis and Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Prostate Cancer Diagnosis and Treatment Players in Global Market
3.2 Top Global Prostate Cancer Diagnosis and Treatment Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnosis and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnosis and Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Cancer Diagnosis and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnosis and Treatment Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnosis and Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnosis and Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Diagnosis and Treatment Market Size Markets, 2021 & 2028
4.1.2 Prostate Specific Antigen Test (PSA)
4.1.3 Digital Rectal Exam (DRE)
4.2 By Type - Global Prostate Cancer Diagnosis and Treatment Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnosis and Treatment Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Diagnosis and Treatment Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnosis and Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Diagnostic clinics
5.1.4 Research centers
5.2 By Application - Global Prostate Cancer Diagnosis and Treatment Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnosis and Treatment Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Diagnosis and Treatment Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Prostate Cancer Diagnosis and Treatment Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Diagnosis and Treatment Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnosis and Treatment Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Diagnosis and Treatment Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028
6.3.2 US Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.3.3 Canada Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.3.4 Mexico Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028
6.4.2 Germany Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.3 France Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.4 U.K. Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.5 Italy Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.6 Russia Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.4.8 Benelux Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028
6.5.2 China Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.5.3 Japan Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.5.4 South Korea Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.5.6 India Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028
6.6.2 Brazil Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.6.3 Argentina Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028
6.7.2 Turkey Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.7.3 Israel Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
6.7.5 UAE Prostate Cancer Diagnosis and Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.1.4 Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 AbbVie
7.2.1 AbbVie Corporate Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.2.4 AbbVie Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.2.5 AbbVie Key News
7.3 Active Biotech
7.3.1 Active Biotech Corporate Summary
7.3.2 Active Biotech Business Overview
7.3.3 Active Biotech Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.3.4 Active Biotech Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.3.5 Active Biotech Key News
7.4 Amgen
7.4.1 Amgen Corporate Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.4.4 Amgen Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.4.5 Amgen Key News
7.5 Astellas Pharma
7.5.1 Astellas Pharma Corporate Summary
7.5.2 Astellas Pharma Business Overview
7.5.3 Astellas Pharma Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.5.4 Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.5.5 Astellas Pharma Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.6.4 AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Corporate Summary
7.7.2 Bavarian Nordic Business Overview
7.7.3 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.7.4 Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.7.5 Bavarian Nordic Key News
7.8 Bayer
7.8.1 Bayer Corporate Summary
7.8.2 Bayer Business Overview
7.8.3 Bayer Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.8.4 Bayer Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.8.5 Bayer Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.9.4 Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.9.5 Bristol-Myers Squibb Key News
7.10 Dendreon
7.10.1 Dendreon Corporate Summary
7.10.2 Dendreon Business Overview
7.10.3 Dendreon Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.10.4 Dendreon Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.10.5 Dendreon Key News
7.11 Endo
7.11.1 Endo Corporate Summary
7.11.2 Endo Business Overview
7.11.3 Endo Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.11.4 Endo Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.11.5 Endo Key News
7.12 Ferring Pharmaceuticals
7.12.1 Ferring Pharmaceuticals Corporate Summary
7.12.2 Ferring Pharmaceuticals Business Overview
7.12.3 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.12.4 Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.12.5 Ferring Pharmaceuticals Key News
7.13 GE Healthcare
7.13.1 GE Healthcare Corporate Summary
7.13.2 GE Healthcare Business Overview
7.13.3 GE Healthcare Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.13.4 GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.13.5 GE Healthcare Key News
7.14 GSK
7.14.1 GSK Corporate Summary
7.14.2 GSK Business Overview
7.14.3 GSK Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.14.4 GSK Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.14.5 GSK Key News
7.15 Ipsen
7.15.1 Ipsen Corporate Summary
7.15.2 Ipsen Business Overview
7.15.3 Ipsen Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.15.4 Ipsen Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.15.5 Ipsen Key News
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Corporate Summary
7.16.2 Johnson & Johnson Business Overview
7.16.3 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.16.4 Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.16.5 Johnson & Johnson Key News
7.17 Pfizer
7.17.1 Pfizer Corporate Summary
7.17.2 Pfizer Business Overview
7.17.3 Pfizer Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.17.4 Pfizer Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.17.5 Pfizer Key News
7.18 Sanofi
7.18.1 Sanofi Corporate Summary
7.18.2 Sanofi Business Overview
7.18.3 Sanofi Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.18.4 Sanofi Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.18.5 Sanofi Key News
7.19 Siemens Healthineers
7.19.1 Siemens Healthineers Corporate Summary
7.19.2 Siemens Healthineers Business Overview
7.19.3 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.19.4 Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.19.5 Siemens Healthineers Key News
7.20 Takeda
7.20.1 Takeda Corporate Summary
7.20.2 Takeda Business Overview
7.20.3 Takeda Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.20.4 Takeda Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.20.5 Takeda Key News
7.21 Teva Pharmaceutical
7.21.1 Teva Pharmaceutical Corporate Summary
7.21.2 Teva Pharmaceutical Business Overview
7.21.3 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.21.4 Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.21.5 Teva Pharmaceutical Key News
7.22 Tolmar Pharmaceuticals
7.22.1 Tolmar Pharmaceuticals Corporate Summary
7.22.2 Tolmar Pharmaceuticals Business Overview
7.22.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Major Product Offerings
7.22.4 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue in Global Market (2017-2022)
7.22.5 Tolmar Pharmaceuticals Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Prostate Cancer Diagnosis and Treatment Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnosis and Treatment Market Drivers in Global Market
Table 3. Prostate Cancer Diagnosis and Treatment Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnosis and Treatment in Global Market
Table 5. Top Prostate Cancer Diagnosis and Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prostate Cancer Diagnosis and Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prostate Cancer Diagnosis and Treatment Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Prostate Cancer Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Prostate Cancer Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Prostate Cancer Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Prostate Cancer Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product Offerings
Table 32. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 33. AbbVie Corporate Summary
Table 34. AbbVie Prostate Cancer Diagnosis and Treatment Product Offerings
Table 35. AbbVie Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Active Biotech Corporate Summary
Table 37. Active Biotech Prostate Cancer Diagnosis and Treatment Product Offerings
Table 38. Active Biotech Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Corporate Summary
Table 40. Amgen Prostate Cancer Diagnosis and Treatment Product Offerings
Table 41. Amgen Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Astellas Pharma Corporate Summary
Table 43. Astellas Pharma Prostate Cancer Diagnosis and Treatment Product Offerings
Table 44. Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Prostate Cancer Diagnosis and Treatment Product Offerings
Table 47. AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bavarian Nordic Corporate Summary
Table 49. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product Offerings
Table 50. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Bayer Corporate Summary
Table 52. Bayer Prostate Cancer Diagnosis and Treatment Product Offerings
Table 53. Bayer Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product Offerings
Table 56. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Dendreon Corporate Summary
Table 58. Dendreon Prostate Cancer Diagnosis and Treatment Product Offerings
Table 59. Dendreon Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Endo Corporate Summary
Table 61. Endo Prostate Cancer Diagnosis and Treatment Product Offerings
Table 62. Endo Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Ferring Pharmaceuticals Corporate Summary
Table 64. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product Offerings
Table 65. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 66. GE Healthcare Corporate Summary
Table 67. GE Healthcare Prostate Cancer Diagnosis and Treatment Product Offerings
Table 68. GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 69. GSK Corporate Summary
Table 70. GSK Prostate Cancer Diagnosis and Treatment Product Offerings
Table 71. GSK Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Ipsen Corporate Summary
Table 73. Ipsen Prostate Cancer Diagnosis and Treatment Product Offerings
Table 74. Ipsen Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Johnson & Johnson Corporate Summary
Table 76. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product Offerings
Table 77. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Pfizer Corporate Summary
Table 79. Pfizer Prostate Cancer Diagnosis and Treatment Product Offerings
Table 80. Pfizer Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Sanofi Corporate Summary
Table 82. Sanofi Prostate Cancer Diagnosis and Treatment Product Offerings
Table 83. Sanofi Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 84. Siemens Healthineers Corporate Summary
Table 85. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product Offerings
Table 86. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 87. Takeda Corporate Summary
Table 88. Takeda Prostate Cancer Diagnosis and Treatment Product Offerings
Table 89. Takeda Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 90. Teva Pharmaceutical Corporate Summary
Table 91. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product Offerings
Table 92. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 93. Tolmar Pharmaceuticals Corporate Summary
Table 94. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product Offerings
Table 95. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 1. Prostate Cancer Diagnosis and Treatment Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnosis and Treatment Market Drivers in Global Market
Table 3. Prostate Cancer Diagnosis and Treatment Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnosis and Treatment in Global Market
Table 5. Top Prostate Cancer Diagnosis and Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prostate Cancer Diagnosis and Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prostate Cancer Diagnosis and Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prostate Cancer Diagnosis and Treatment Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Prostate Cancer Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Prostate Cancer Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Prostate Cancer Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Prostate Cancer Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Product Offerings
Table 32. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 33. AbbVie Corporate Summary
Table 34. AbbVie Prostate Cancer Diagnosis and Treatment Product Offerings
Table 35. AbbVie Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Active Biotech Corporate Summary
Table 37. Active Biotech Prostate Cancer Diagnosis and Treatment Product Offerings
Table 38. Active Biotech Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Amgen Corporate Summary
Table 40. Amgen Prostate Cancer Diagnosis and Treatment Product Offerings
Table 41. Amgen Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Astellas Pharma Corporate Summary
Table 43. Astellas Pharma Prostate Cancer Diagnosis and Treatment Product Offerings
Table 44. Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Prostate Cancer Diagnosis and Treatment Product Offerings
Table 47. AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bavarian Nordic Corporate Summary
Table 49. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Product Offerings
Table 50. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Bayer Corporate Summary
Table 52. Bayer Prostate Cancer Diagnosis and Treatment Product Offerings
Table 53. Bayer Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Product Offerings
Table 56. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Dendreon Corporate Summary
Table 58. Dendreon Prostate Cancer Diagnosis and Treatment Product Offerings
Table 59. Dendreon Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Endo Corporate Summary
Table 61. Endo Prostate Cancer Diagnosis and Treatment Product Offerings
Table 62. Endo Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Ferring Pharmaceuticals Corporate Summary
Table 64. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product Offerings
Table 65. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 66. GE Healthcare Corporate Summary
Table 67. GE Healthcare Prostate Cancer Diagnosis and Treatment Product Offerings
Table 68. GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 69. GSK Corporate Summary
Table 70. GSK Prostate Cancer Diagnosis and Treatment Product Offerings
Table 71. GSK Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Ipsen Corporate Summary
Table 73. Ipsen Prostate Cancer Diagnosis and Treatment Product Offerings
Table 74. Ipsen Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Johnson & Johnson Corporate Summary
Table 76. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Product Offerings
Table 77. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Pfizer Corporate Summary
Table 79. Pfizer Prostate Cancer Diagnosis and Treatment Product Offerings
Table 80. Pfizer Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Sanofi Corporate Summary
Table 82. Sanofi Prostate Cancer Diagnosis and Treatment Product Offerings
Table 83. Sanofi Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 84. Siemens Healthineers Corporate Summary
Table 85. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Product Offerings
Table 86. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 87. Takeda Corporate Summary
Table 88. Takeda Prostate Cancer Diagnosis and Treatment Product Offerings
Table 89. Takeda Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 90. Teva Pharmaceutical Corporate Summary
Table 91. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Product Offerings
Table 92. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 93. Tolmar Pharmaceuticals Corporate Summary
Table 94. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Product Offerings
Table 95. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Prostate Cancer Diagnosis and Treatment Segment by Type in 2021
Figure 2. Prostate Cancer Diagnosis and Treatment Segment by Application in 2021
Figure 3. Global Prostate Cancer Diagnosis and Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnosis and Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue in 2021
Figure 8. By Type - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 12. US Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 24. China Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AbbVie Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Active Biotech Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Dendreon Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Endo Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. GSK Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Ipsen Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Pfizer Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Sanofi Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Takeda Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Prostate Cancer Diagnosis and Treatment Segment by Type in 2021
Figure 2. Prostate Cancer Diagnosis and Treatment Segment by Application in 2021
Figure 3. Global Prostate Cancer Diagnosis and Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnosis and Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnosis and Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnosis and Treatment Revenue in 2021
Figure 8. By Type - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 12. US Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 24. China Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Prostate Cancer Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prostate Cancer Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AbbVie Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Active Biotech Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Amgen Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Astellas Pharma Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bavarian Nordic Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bayer Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Dendreon Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Endo Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Ferring Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. GE Healthcare Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. GSK Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Ipsen Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Johnson & Johnson Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Pfizer Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Sanofi Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Siemens Healthineers Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Takeda Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Teva Pharmaceutical Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
